Tsokos, G. C., Lo, M. S., Costa Reis, P. & Sullivan, K. E. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat. Rev. Rheumatol. 12, 716–730 (2016).
CAS PubMed Article Google Scholar
Marshak-Rothstein, A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823–835 (2006).
CAS PubMed PubMed Central Article Google Scholar
Teichmann, L. L., Schenten, D., Medzhitov, R., Kashgarian, M. & Shlomchik, M. J. Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus. Immunity 38, 528–540 (2013).
CAS PubMed PubMed Central Article Google Scholar
Christensen, S. R. et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25, 417–428 (2006).
CAS PubMed Article Google Scholar
Bossaller, L. et al. TLR9 deficiency leads to accelerated renal disease and myeloid lineage abnormalities in pristane-induced murine lupus. J. Immunol. 197, 1044–1053 (2016).
CAS PubMed Article Google Scholar
Fairhurst, A. M. et al. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. Eur. J. Immunol. 38, 1971–1978 (2008).
CAS PubMed PubMed Central Article Google Scholar
Nickerson, K. M., Wang, Y., Bastacky, S. & Shlomchik, M. J. Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL mice. PLoS ONE 12, e0173471 (2017).
PubMed PubMed Central Article Google Scholar
Jackson, S. W. et al. Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J. Immunol. 192, 4525–4532 (2014).
CAS PubMed Article Google Scholar
Scofield, R. H. et al. Klinefelter’s syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum. 58, 2511–2517 (2008).
PubMed PubMed Central Article Google Scholar
Lee, Y. H., Choi, S. J., Ji, J. D. & Song, G. G. Association between Toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update. Lupus 25, 593–601 (2016).
CAS PubMed Article Google Scholar
Garcia-Ortiz, H. et al. Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann. Rheum. Dis. 69, 1861–1865 (2010).
CAS PubMed Article Google Scholar
Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349–356 (2022).
CAS PubMed PubMed Central Article Google Scholar
Nickerson, K. M. et al. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J. Immunol. 184, 1840–1848 (2010).
CAS PubMed Article Google Scholar
Kim, Y. M., Brinkmann, M. M., Paquet, M. E. & Ploegh, H. L. UNC93B1 delivers nucleotide-sensing Toll-like receptors to endolysosomes. Nature 452, 234–238 (2008).
CAS PubMed Article Google Scholar
Fukui, R. et al. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J. Exp. Med. 206, 1339–1350 (2009).
CAS PubMed PubMed Central Article Google Scholar
Fukui, R. et al. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity 35, 69–81 (2011).
CAS PubMed Article Google Scholar
Stoehr, A. D. et al. TLR9 in peritoneal B-1b cells is essential for production of protective self-reactive IgM to control TH17 cells and severe autoimmunity. J. Immunol. 187, 2953–2965 (2011).
CAS PubMed Article Google Scholar
Tilstra, J. S. et al. B cell-intrinsic TLR9 expression is protective in murine lupus. J. Clin. Invest. 130, 3172–3187 (2020).
CAS PubMed PubMed Central Article Google Scholar
Peter, M. E., Kubarenko, A. V., Weber, A. N. & Dalpke, A. H. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. J. Immunol. 182, 7690–7697 (2009).
CAS PubMed Article Google Scholar
Christensen, S. R. et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202, 321–331 (2005).
CAS PubMed PubMed Central Article Google Scholar
Nickerson, K. M., Cullen, J. L., Kashgarian, M. & Shlomchik, M. J. Exacerbated autoimmunity in the absence of TLR9 in MRL.Faslpr mice depends on Ifnar1. J. Immunol. 190, 3889–3894 (2013).
CAS PubMed Article Google Scholar
Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085–2088 (1998).
CAS PubMed Article Google Scholar
Syrett, C. M., Sierra, I., Beethem, Z. T., Dubin, A. H. & Anguera, M. C. Loss of epigenetic modifications on the inactive X chromosome and sex-biased gene expression profiles in B cells from NZB/W F1 mice with lupus-like disease. J. Autoimmun. 107, 102357 (2020).
CAS PubMed Article Google Scholar
Souyris, M. et al. TLR7 escapes X chromosome inactivation in immune cells. Sci. Immunol. 3, eaap8855 (2018).
Azulay-Debby, H., Edry, E. & Melamed, D. CpG DNA stimulates autoreactive immature B cells in the bone marrow. Eur. J. Immunol. 37, 1463–1475 (2007).
CAS PubMed Article Google Scholar
Nickerson, K. M. et al. TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation. J. Immunol. 190, 1447–1456 (2013).
CAS PubMed Article Google Scholar
Scharer, C. D. et al. Epigenetic programming underpins B cell dysfunction in human SLE. Nat. Immunol. 20, 1071–1082 (2019).
CAS PubMed PubMed Central Article Google Scholar
Wang, S. et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE. Nat. Commun. 9, 1758 (2018).
PubMed PubMed Central Article Google Scholar
Saelee, P., Kearly, A., Nutt, S. L. & Garrett-Sinha, L. A. Genome-wide identification of target genes for the key B cell transcription factor Ets1. Front Immunol. 8, 383 (2017).
PubMed PubMed Central Article Google Scholar
Kikuchi, H., Nakayama, M., Takami, Y., Kuribayashi, F. & Nakayama, T. EBF1 acts as a powerful repressor of Blimp-1 gene expression in immature B cells. Biochem. Biophys. Res. Commun. 422, 780–785 (2012).
CAS PubMed Article Google Scholar
Schmidlin, H. et al. Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression. Blood 112, 1804–1812 (2008).
CAS PubMed PubMed Central Article Google Scholar
Willis, S. N. et al. Environmental sensing by mature B cells is controlled by the transcription factors PU.1 and SpiB. Nat. Commun. 8, 1426 (2017).
PubMed PubMed Central Article Google Scholar
Carotta, S. et al. The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation. J. Exp. Med. 211, 2169–2181 (2014).
PubMed PubMed Central Article Google Scholar
Garrett-Sinha, L. A., Kearly, A. & Satterthwaite, A. B. The role of the transcription factor Ets1 in lupus and other autoimmune diseases. Crit. Rev. Immunol. 36, 485–510 (2016).
PubMed PubMed Central Article Google Scholar
Thomsen, I. et al. RUNX1 regulates a transcription program that affects the dynamics of cell cycle entry of naive resting B cells. J. Immunol. 207, 2976–2991 (2021).
CAS PubMed PubMed Central Article Google Scholar
Emslie, D. et al. Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor α chain expression on activated B cells. J. Exp. Med. 205, 409–421 (2008).
CAS PubMed PubMed Central Article Google Scholar
Scharer, C. D., Barwick, B. G., Guo, M., Bally, A. P. R. & Boss, J. M. Plasma cell differentiation is controlled by multiple cell division-coupled epigenetic programs. Nat. Commun. 9, 1698 (2018).
PubMed PubMed Central Article Google Scholar
Goel, R. R. et al. Interferon λ promotes immune dysregulation and tis
留言 (0)